G enetically encoded optical reporters, such as the green fluorescent protein (GFP), have enabled important advances in biology by making it possible to image cellular and molecular processes, such as gene expression 1 . However, as light is scattered strongly by tissues, fluorescent and bioluminescent reporters are inadequate for many studies of living organisms. By contrast, magnetic resonance imaging (MRI) routinely delivers non-invasive images of anatomy at high resolution 2 . Thus, there has been a long-standing interest in developing analogues of GFP for MRI 3 . Unfortunately, previous efforts to develop such reporters have yielded constructs with low molecular sensitivity. This limitation arises because all such reporters produce signal changes via their effect on thermally polarized 1 H nuclei, and must therefore be present in biological specimens at concentrations sufficient to interact with a substantial fraction of the nuclei, 100 molar 1 H (primarily in H 2 O), on subsecond timescales 4 . As a result, practical detection limits were in the micromolar range 3, 4 compared to the nanomolar range for GFP 5 .
This sensitivity barrier can be overcome through the use of hyperpolarized MRI. This form of imaging exploits nuclei that can be hyperpolarized (prepared in non-equilibrium states of artificially high spin polarization) and introduced into the body by injection or inhalation 6, 7 . In particular, the spin polarization of 129 Xe can be increased 10,000-fold by spin-exchange optical pumping 8 , such that its magnetic resonance signal in a saturated aqueous solution at millimolar concentrations is comparable to that of 110 molar thermally polarized 1 H. After introduction by inhalation, this mostly inert and biocompatible element distributes rapidly into tissues such as the lungs 9 , brain 10 , heart and kidneys 11 , where its non-equilibrium polarization is maintained over a lifetime (T 1 ) of 4-16 seconds 12, 13 . As the signals measured in these tissues arise from 129 Xe concentrations several orders of magnitude lower than that of water, the detectable concentrations of xenon-active MRI reporters (that is, the concentrations needed to interact with a substantial fraction of the xenon and alter its signal) should themselves be much lower than their 1 H counterparts. Previous work on molecular reporters for hyperpolarized 129 Xe MRI focused on synthetic xenon-binding constructs, such as cryptophanes [14] [15] [16] or perfluorocarbon droplets 17 , that alter the magnetic resonance frequency of bound 129 Xe. These reporters can be detected directly via their bound-xenon chemical peak or through chemical exchange saturation transfer (HyperCEST) 18, 19 . In the latter approach, saturation pulses are applied at the chemical shift of xenon bound to the reporter and a rapid exchange between reporter-bound and dissolved xenon results in saturation transfer between these two compartments, which reduces the signal in the dissolved xenon pool. Using this amplified detection scheme, synthetic HyperCEST reporters are detectable at nanomolar or lower concentrations 17, [20] [21] [22] . However, despite recent progress [23] [24] [25] [26] [27] , synthetic constructs remain challenging to produce and difficult to deliver to cells or link to specific biological processes. It is therefore highly desirable to develop HyperCEST reporters encoded by genes, although this would at first appear difficult because xenon, a noble gas, interacts with proteins only weakly.
To overcome this challenge, we turned to a unique class of genetically encoded gas nanostructures from buoyant microbes. Gas vesicles (GVs) are nanoscale gas compartments (typically 50-500 nm in size) formed entirely from protein that are expressed in several species of waterborne halobacteria and cyanobacteria as a means to control buoyancy and thereby migrate to optimal depths for access to light and nutrients 28, 29 . The contents of the GVs are in constant exchange with gas molecules dissolved in the surrounding media, and they are permeable to gases that range in size from hydrogen to perfluorocyclobutane 30 . GVs mostly comprise copies of a single highly conserved protein, GvpA, but their formation requires at least eight genes contained in GV gene clusters 28 . A six kilobase cluster that encodes 11 GV genes has been expressed heterologously in E. coli, which resulted in the formation of GVs and increased cellular buoyancy 31 . We hypothesized that dissolved 129 Xe would partition into GVs, where it would form a gaseous phase with a distinct chemical shift, and would rapidly exchange between GVs and solution, thus enabling the use of these nanostructures as genetically encoded HyperCEST reporters (Fig. 1a) . We also hypothesized that GVs from different species, which have distinct shapes and sizes, would have different chemical shifts and so allow multiplexed imaging.
Results
GVs produce HyperCEST contrast at picomolar concentrations. We tested the ability of GVs isolated from Anabaena flos-aquae to produce HyperCEST contrast in aqueous solutions that contained hyperpolarized 129 Xe at 9.4 T. The GVs were released from cells by hypertonic lysis and purified by centrifugally assisted flotation, and their concentration, purity, monodispersity and integrity were determined by total-protein assay and transmission electron microscopy (TEM) (see Methods). These nanostructures have a diameter of approximately 145 nm and lengths that range from 250 to 1,000 nm (Fig. 1d, Supplementary Fig. 1a) .
At GV nanostructure concentrations of up to 400 pM, no NMR signal other than the main dissolved xenon peak was detectable (Fig. 1b, black) . However, radiofrequency (RF) saturation applied at an offset of 31.2 ppm (relative to gaseous xenon) produced a dramatic decrease in the dissolved 129 Xe signal in a saturationtime and power-dependent manner (Fig. 1b) . After 6.5 seconds of exposure to a 33.6 mT (396 Hz) continuous-wave field, the dissolved xenon signal was completely saturated. We measured this signal as a function of saturation frequency, which revealed a unique GV saturation peak at 31.2 ppm, in addition to the saturation peak for free xenon at 195 ppm (Fig. 1c, red) . As a control, we irreversibly collapsed GVs through the application of hydrostatic pressure before performing NMR spectroscopy (Fig. 1d) . These collapsed GVs no longer produced saturation contrast, which confirms that their gas-filled interior was responsible for this effect (Fig. 1c, black) . The presence of intact GVs broadened the direct saturation peak of aqueous 129 Xe and the xenon signal itself ( Supplementary  Fig. 2 ). Such broadening is characteristic of a chemical exchange Xe nuclei (black) exchange into GVs, where they have a unique NMR frequency (red) at which they can be saturated by RF pulses. Saturated (grey) xenon returns to the bulk, which causes a decrease in bulk 129 Xe signal. b, NMR spectra of 129 Xe in buffer that contained 400 pM GVs after saturation for the specified amount of time at 31.2 ppm. Spectra are offset for visibility. a.u., arbitrary units. c, Frequency-dependent saturation spectra for intact (red) and collapsed (black) GVs. Each spectrum is an average of two. d, Transmission electron micrographs of intact (left and centre) and collapsed (right) GVs used in this study. Scale bars, 200 nm. e, Concentration dependence of saturation contrast generated by GVs with saturation times that correspond colour-wise to those in b (n ¼ 3 for each data point). Data are fitted with monoexponential curves as a visual aide. f, Saturation contrast image of a three-compartment phantom that contains 400 pM GVs, 100 pM GVs and buffer. RF saturation and image-averaging parameters are listed in Supplementary Tables 1 and 2 . All the GVs used here were isolated from A. flos-aquae. Error bars represent s.e.m. mechanism, as previously observed with 1 H CEST agents [32] [33] [34] . It may additionally result from the magnetic susceptibility difference between gas-containing GVs and the media.
To determine the molecular sensitivity of GVs as an MRI reporter, we performed HyperCEST measurements across a range of GV concentrations and saturation times (Fig. 1e) . With 6.5 seconds of saturation at 31.2 ppm, 8 pM GVs were sufficient to produce a 7.0+0.4% saturation contrast (defined as the difference in aqueous 129 Xe signal after on-resonance saturation relative to an off-resonance control); with 400 pM GVs, saturation contrast reached 97.2+1.0%. With saturation times of 0.4 and 0.8 seconds, which are much shorter than the in vivo T 1 of 129 Xe, 400 pM GVs produced saturation contrasts of 16.2+2.3% and 33.0+1.9%, respectively, and a statistically significant contrast was observed at 25 pM with a realistic saturation time of 1.63 seconds. Thus, GV HyperCEST reporters have a molecular sensitivity in the mid-picomolar range. We used HyperCEST MRI to image GVs in a three-compartment phantom that contained buffer, 100 pM GVs or 400 pM GVs. Nearly complete saturation could be seen in the 400 pM chamber; significant saturation contrast was also present at the lower concentration (Fig 1f) .
Unique chemical shifts of GVs from different species enable multiplexed imaging. To test our hypothesis that differences in the shape and size of GVs encoded in diverse bacterial species would result in distinct HyperCEST saturation frequencies, we acquired saturation spectra as a function of frequency from solutions that contained intact Halobacteria sp. NRC-1, Microcystis sp. and E. coli cells in their appropriate media. The first two species expressed native GV genes; the E. coli were transformed with a plasmid that contained a minimal GV-forming gene cluster from Bacillus megaterium 31 . As hypothesized, each species had a unique saturation-frequency profile, with maximal saturation at 14.4 ppm, 30.6 ppm and 51.4 ppm for Halobacteria sp. NRC-1, Microcystis sp. and E. coli, respectively (Fig. 2a) . These distinct saturation profiles enabled multiplexed MRI to be performed by applying saturation at three different frequencies (Fig. 2b-e) , the result being analogous to fluorescent imaging using GFP derivatives with distinct optical spectra. The downfield-shifted aqueous xenon peak in the halobacterial spectrum at 226 ppm probably resulted from the high salt content of its media (25% NaCl); this shift was also evident in the corresponding media-only saturation spectrum ( Supplementary Fig. 3 ). In addition, GVs purified from Halobacteria sp. NRC-1 into a low-salt buffer (shown in the TEM image in Supplementary Fig. 1b ) produced a broadened aqueous xenon saturation peak centred at the more typical 195 ppm, with the peak attributable to GVs still centred at approximately 14.4 ppm ( Supplementary Fig. 4) . Finally, purified Halobacteria sp. NRC-1 GVs were used in place of intact cells in the magnetic resonance images shown in Fig. 2b -e so that the dissolved xenon resonance peak would be consistent across specimens for the purpose of pulse programming.
Heterologously expressed GVs enable quantitative imaging of gene expression. We tested the ability of GVs to act as quantitative reporters of gene expression by placing their expression in E. coli under the control of a promoter inducible by isopropyl b-D-1-thiogalactopyranoside (IPTG, Fig. 3a ). Overnight induction with IPTG resulted in GV expression (TEM image in Supplementary Fig. 1c ) and a robust HyperCEST image contrast that was absent from cells that were not induced and from induced cells that contained a control vector lacking GV genes (Fig. 3b,c) . The magnitude of HyperCEST contrast was dependent on the dose of IPTG, which confirms the utility of GVs as quantitative reporters of gene expression.
Chemically functionalized GVs enable non-invasive labelling of breast cancer cells. To assess the potential utility of GVs as targeted biosensors, we functionalized purified GVs from A. flos-aquae with biotin via N-hydroxysuccinimide linkages to lysine side chains on the GV surface and attached streptavidinfunctionalized antibodies against the HER2 receptor (Fig. 3d) . Anti-HER2 GVs were used to label the HER2-expressing breast cancer cell line SKBR3 or control Jurkat cells. HyperCEST imaging easily distinguished a suspension of labelled SKBR3 cells from identically treated Jurkat cells (Fig. 3e,f ) . The targeted breast cancer cells exhibited a saturation contrast of 78.53+1.38%.
Pharmacokinetic modelling suggests the feasibility of in vivo 129 Xe HyperCEST. The use of GVs in animals as genetically encoded or injected reporters will require the development of methods for in vivo HyperCEST imaging. Although 129 Xe MRI of tissues is still in its relative infancy, hyperpolarized xenon dissolved after inhalation has been imaged robustly in highly vascularized organs such as the brain 10, 13, 35, 36 . To assess the feasibility of combining this imaging approach with GV HyperCEST, we adapted published pharmacokinetic models of inhaled hyperpolarized 129 Xe (refs 37,38) to include a saturation and imaging pulse sequence (using methods and parameters detailed in the Supplementary Information and Supplementary  Tables 3 and 4) . Consistent with previous findings, our model predicted a peak brain-tissue concentration of 22 mM hyperpolarized 129 Xe, assuming the inhalation of isotopically enriched 129 Xe polarized to 10% (Supplementary Figs 5 and 6 ). This would result in an MRI signal-to-noise ratio 64-fold lower than that of protons 38 , but substantially higher than the that of 19 F MRI, which is increasingly used for molecular imaging 39 . Importantly, although 129 Xe magnetization is non-renewable, our model confirms that the combination of repeated xenon inhalation and low flip-angle sequences permits continuous imaging 10, 35, 36 ( Supplementary Fig. 6a,b) . On the application of an on-resonance saturation pulse, the model predicts a 73% signal decrease in GVcontaining regions (compared to an off-resonance control) and minimal change in regions devoid of GVs ( Supplementary  Fig. 6b,c) . That this detection scheme is ratiometric (that is, internally normalized by measuring the signal in a given voxel with and without an on-resonance saturation pre-pulse) should make GV imaging relatively robust to any spatial inhomogeneity in the distribution of xenon in the target tissue. Overall, these modelling results support the feasibility of imaging GV-based HyperCEST reporters in the brain and similarly vascularized organs, which can be explored in future experimental studies. 
Discussion
Our results establish GVs as the first genetically encoded molecular reporters for hyperpolarized MRI. Compared to analogous 1 H-CEST reporter genes 40 , the detection limit of GVs represents an in vitro sensitivity improvement of 10,000-fold and 100-fold in terms of molar concentration (25 pM) and protein mass ( 2.5 mg ml 21 ), respectively. Furthermore, because genetic variation in the shape, size and/or chemical properties of GVs from different species results in unique 129 Xe offset frequencies, it is possible to perform multiplexed imaging of GVs analogous to multicolour fluorescent protein microscopy 1 . Although such multiplexing has also been shown with 1 H MRI CEST constructs 41 and magnetic microstructures 42 , typically the former were used at millimolar concentrations, and the latter are not encoded genetically.
The ability of GVs to label and quantify gene expression in bacteria, as demonstrated here, may have utility in various synthetic biological applications 43 and studies of host-microbe symbiosis 44 , immune defence 45 and tumour growth 46 . GV expression in mammalian cells would additionally permit non-invasive imaging of stem-cell migration, immune function, tumour metastasis and other biological processes that involve cell expansion, migration and gene expression. At approximately six kilobases, the size of minimal GV gene clusters is compatible with the capacity of lentiviral vectors for cell transduction and labelling 47 . In addition, standard chemical conjugation makes it possible to use GVs as exogenous molecular labels, as shown here with the detection of breast cancer cells. Further engineering of the biochemical properties of GVs may also be possible at the genetic level, for example by creating fusion constructs of GV proteins with functionalities for targeting or for altered biodistribution 48 . Additionally, given the relative ease of growing large quantities of bacteria and the straightforward purification of GVs based on buoyancy, these imaging agents lend themselves to widespread production and use.
For in vivo imaging, GVs expressed in cells, encoded in viral vectors or formulated in a purified, biofunctionalized form could be injected into target tissues or systemic circulation. The resulting distribution of GVs in the body would be revealed subsequently by 129 Xe MRI using the HyperCEST technique. Although such in vivo imaging was not attempted experimentally, our pharmacokinetic model suggests that it is feasible using inhaled hyperpolarized xenon. In addition, alternative methods of xenon delivery, such as through lipid emulsions 49 and extracorporeal membrane gas exchange 50 , may further improve the strength and consistency of tissue 129 Xe MRI signals. Importantly, with HyperCEST imaging the timing, route and kinetics of xenon delivery are independent of the expression or delivery of GVs and may be optimized separately. Continuing advances in in vivo 129 Xe MRI combined with, and stimulated by, the introduction of the first genetically encoded reporters for this modality promise to deliver the sensitivity advantages of hyperpolarization to a broader range of biological imaging applications.
Methods
A detailed description of the materials and methods is provided in the Supplementary Information.
Specimen preparation. Microcystis sp. (CCAP strain 1450/13), A. flos-aquae (CCAP strain 1403/13F) and Halobacteria sp. NRC-1 were cultured using standard methods. GVs were isolated using tonic lysis and purified by repeated centrifugally assisted flotation into Tris-HCl buffer. Collapse was performed through the manual application of hydrostatic pressure to GVs inside a capped syringe prior to spectroscopy or imaging. GV concentrations were estimated by pressure-sensitive attenuance at 500 nm (D 500,PS ) calibrated by the results of a bicinchoninic acid assay. The lysis of A. flos-aquae cells yielded 0.66+0.10 nmol GV per gram of dry cell pellet (n ¼ 4). Intact microorganisms were imaged in their applicable growth media. The pNL29 GV gene cluster from B. megaterium was expressed in BL21 DE3 E. coli in an IPTG-inducible plasmid. Cells were induced at D 600 ≈ 0.4 and grown overnight at 30 8C. If necessary, cells were concentrated using a 0.22 mm filter. Imaging of E. coli was performed in phosphate buffered saline (PBS). For mammalian experiments, SKBR3 and Jurkat cells were cultured in standard media. Prior to imaging, they were harvested and washed with PBS that contained 2% bovine serum albumin (BSA). Anti-HER2 GVs were prepared by chemically biotinylating A. flos-aquae GVs using sulfo-NHS-LC-biotin (6-(biotinamidohexanoylamido)hexanoic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt) and purified by centrifugally assisted flotation, and then streptavidin-conjugated anti-HER2 antibodies (clone N12) were attached. Cells were incubated with 400 pM functionalized GVs in PBS with 2% BSA for one hour at 4 8C, washed twice and resuspended in 0.6 ml PBS.
Hyperpolarized 129
Xe spectroscopy and imaging. 129 Xe NMR and MRI were performed using a 9.4 T spectrometer with dual-tuned 5 mm and 10 mm probes. Hyperpolarized xenon was prepared in continuous mode from a gas mixture of 2% Xe (natural abundance), 10% N 2 and 88% He by spin-exchange optical pumping, using a home-built polarizing apparatus, to a polarization of approximately 2%. Hyperpolarized gas was bubbled into custom phantoms through capillary tubes under 1.57-1.7 atm. A ten second bubble period was followed by a five second wait period to allow bubbles to dissipate and the solution to settle. Chemical shifts were referenced to gaseous 129 Xe. Saturation was applied using continuous wave pulses (the parameters are specified in Supplementary Table 1 ). Saturation contrast represents the normalized difference between on-resonance and off-resonance signals. Frequency-dependent saturation spectra were obtained by measuring the aqueous 129 Xe signal as a function of saturation pulse offset, varied from 277.2 ppm to 284.4 ppm. Imaging was performed in a three-compartment phantom inside a 10 mm probe. Xenon images were generated with a fast spin echo (FSE) sequence with eight-echo trains and 10 ms echo time. Including bubbling, wait and saturation times, the overall repetition time (TR) was 17.58 or 19.08 seconds. Other image parameters are listed in Supplementary Table 2. All images were axial without slice selection, and the k-space matrix comprised 32 points in the readout dimension and 16 phase-encoding points. The field of view was 20 mm by 20 mm. Image processing included zero-filling the k-space matrix 2× in each dimension and thresholding images at 3× root mean square noise. Saturation maps were produced by comparing off-resonance and on-resonance 129 Xe images (Supplementary Fig. 7 ). Proton images were also acquired with a FSE imaging sequence (TR ¼ 1. TEM. TEM images were obtained on a Philips/FEI (Hillsboro) Tecnai 12 microscope operating at 120 kV. GV samples were negatively stained with 2% uranyl acetate and deposited on a carbon-coated formvar grid. Thin-section TEM E. coli specimens were prepared by fixing the cells in glutaraldehyde, osmium tetroxide and ferrous cyanide, dehydrating in acetone, embedding in epoxy resin and sectioning under ambient pressure.
Pharmacokinetic model. Pharmacokinetic modelling was performed in MATLAB using the equations, assumptions and parameters described in Supplementary Section 4 and Supplementary Tables 3 and 4. 
